Changhai Hospital
Clinical trials sponsored by Changhai Hospital, explained in plain language.
-
Engineered immune cells take on kidney disease in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called anti-CD19/BCMA universal CAR T cells for people with relapsed or refractory immune-mediated kidney disease. The therapy uses specially engineered immune cells to target and destroy harmful B cells that drive the disease. The mai…
Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New pill may stop chemo-related bleeding risk in stomach and colon cancer patients
Disease control Recruiting nowThis study tests a drug called hetrombopag to prevent dangerously low platelet counts caused by chemotherapy in people with gastrointestinal tumors (like stomach or colon cancer). About 40 participants will take the pill daily for 14 days after chemo. The goal is to see if it kee…
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Freeze and fight: new combo therapy aims to save bladders in cancer patients
Disease control Recruiting nowThis study tests a new approach to treat high-risk bladder cancer without removing the bladder. It combines freezing the tumor during surgery with immunotherapy and low-dose chemotherapy. The goal is to see if this can help patients live longer and keep their bladder, compared to…
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Engineered immune cells take on pancreatic cancer in early trial
Disease control Recruiting nowThis early-stage study tests a new treatment called CAR-NK cells (CL-NK-003) in 9 people with advanced pancreatic cancer that has not responded to standard therapies. The main goal is to check safety and find the right dose. Researchers will also watch for signs that the treatmen…
Phase: PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Universal CAR-T cells take on lupus and more in early trial
Disease control Recruiting nowThis early-phase study tests a new type of CAR-T cell therapy (called KN3601) for people with severe autoimmune diseases like lupus, scleroderma, Sjögren's syndrome, rheumatoid arthritis, and vasculitis that haven't responded to standard treatments. The therapy uses specially eng…
Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Personalized cell therapy targets tough pancreatic cancer
Disease control Recruiting nowThis study tests a new treatment for people with advanced pancreatic cancer that has a specific genetic change (KRAS G12V). The treatment uses the patient's own immune cells, modified in a lab to better recognize and attack cancer cells. The goal is to see if this therapy is safe…
Phase: PHASE1, PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Poop pills could fight deadly pancreas infections
Disease control Recruiting nowThis study tests whether transplanting healthy gut bacteria (FMT) can prevent serious infections in people with moderate to severe acute pancreatitis. About 80 adults will receive either FMT or a placebo through a feeding tube. The goal is to see if FMT lowers the risk of infecte…
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Bladder cancer breakthrough? new combo aims to save bladders
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug toripalimab to standard BCG treatment can stop high-risk bladder cancer from returning after surgery. About 31 adults with aggressive non-muscle-invasive bladder cancer will receive the combination for 6 months. The goal is t…
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
AI reads CT scans to outsmart pancreatic disease — fewer unnecessary surgeries ahead?
Diagnosis Recruiting nowThis study is testing an artificial intelligence (AI) system that uses contrast-enhanced CT scans to help doctors make better decisions about pancreatic diseases. The AI will classify patients into three groups: needing surgery or treatment, close monitoring, or routine follow-up…
Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Jun 15, 2026 18:55 UTC
-
Poop pills may stop deadly infections in pancreatitis patients
Prevention Recruiting nowThis study tests whether transferring healthy gut bacteria (fecal transplant) can prevent infections like pneumonia and infected pancreatic tissue in people with severe acute pancreatitis. About 150 adults aged 18-75 will receive either a fecal transplant or a placebo through a f…
Phase: NA • Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jun 15, 2026 19:03 UTC
-
Fluid combo may stop pancreatitis after stone blasting
Prevention Recruiting nowThis study tests whether giving extra fluids through a vein along with a standard anti-inflammatory drug (indometacin) can better prevent pancreatitis after a procedure that uses shock waves to break up pancreatic stones. About 1250 adults with painful chronic pancreatitis will b…
Phase: NA • Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jun 15, 2026 18:56 UTC
-
Lower dose, same protection? new trial aims to prevent ERCP pancreatitis
Prevention Recruiting nowThis study tests whether a lower dose (50mg) of rectal indomethacin works as well as the standard dose (100mg) to prevent pancreatitis after an ERCP procedure. About 1,366 adults scheduled for ERCP will be randomly assigned to receive either dose 30 minutes before the procedure. …
Phase: PHASE4 • Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jun 15, 2026 18:56 UTC
-
New diet could make colonoscopy prep less miserable for IBD patients
Symptom relief Recruiting nowThis study tests whether a pre-packaged low-residue nutrition formula (Maifu Changqing®) can improve bowel cleanliness and comfort during colonoscopy preparation for 1,000 adults with inflammatory bowel disease (IBD). Participants will be randomly assigned to receive either the s…
Phase: NA • Sponsor: Changhai Hospital • Aim: Symptom relief
Last updated Jun 16, 2026 12:55 UTC
-
New diet could simplify colonoscopy prep for IBD patients
Symptom relief Recruiting nowThis study tests whether a pre-packaged low-residue diet (Maifu Changqing®) helps people with inflammatory bowel disease (IBD) prepare for colonoscopy more comfortably and effectively. About 500 adults with IBD will be enrolled across multiple hospitals in China. The goal is to s…
Phase: NA • Sponsor: Changhai Hospital • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC
-
New study aims to improve colonoscopy prep for IBD patients
Knowledge-focused Recruiting nowThis study involves 1,000 adults with inflammatory bowel disease (IBD) who need a colonoscopy. Researchers want to see how well current bowel preparation methods work and what factors lead to poor preparation. The goal is to create a tool that predicts which patients might have t…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
New database aims to spot early stomach cancer signs
Knowledge-focused Recruiting nowThis study is gathering images from special cameras and CT scans, along with lab results, to create a database for early upper gastrointestinal cancers and precancerous conditions. About 500 adults who need certain procedures will take part. The goal is to help doctors better rec…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:04 UTC